{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:16:27Z","timestamp":1773152187580,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1215\/15228517-2006-003","type":"journal-article","created":{"date-parts":[[2006,5,25]],"date-time":"2006-05-25T20:45:12Z","timestamp":1148589912000},"page":"280-283","source":"Crossref","is-referenced-by-count":53,"title":["Treatment-related myelodysplasia\/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature1"],"prefix":"10.1093","volume":"8","author":[{"given":"Vanita","family":"Noronha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K.","family":"Ballen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Kracher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Baehring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Henson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,7,1]]},"reference":[{"key":"key\n\t\t\t\t20171013103544_REF1","doi-asserted-by":"crossref","unstructured":"Ballen, K.K. (2005) New trends in umbilical cord blood transplantation. Blood105, 3786-3792.","DOI":"10.1182\/blood-2004-10-4125"},{"key":"key\n\t\t\t\t20171013103544_REF2","doi-asserted-by":"crossref","unstructured":"Ballen, K.K., Gilliland, D.G., Guinan, E.C., Hsieh, C.C., Parsons, S.K., Rimm, I.J., Ferrara, J.L., Bierer, B.E., Weinstein, H.J., and Antin, J.H. (1997) Bone marrow transplantation for therapy-related myelodysplasia: Comparison with primary myelodysplasia. Bone Marrow Transplant.20, 737-743.","DOI":"10.1038\/sj.bmt.1700971"},{"key":"key\n\t\t\t\t20171013103544_REF3","doi-asserted-by":"crossref","unstructured":"Brada, M., Judson, I., Beale, P., Moore, S., Reidenberg, P., Statkevich, P., Dugan, M., Batra, V., and Cutler, D. (1999) Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies. Br. J. Cancer81, 1022-1030.","DOI":"10.1038\/sj.bjc.6690802"},{"key":"key\n\t\t\t\t20171013103544_REF4","doi-asserted-by":"crossref","unstructured":"Genot, J.Y., Krulik, M., Poisson, M., van Efferterre, R., Renoux, M., Audebert, A.A., Canuel, C., Smadja, N., and Debray, J. (1983) Two cases of acute leukemia following treatment of malignant glioma. Cancer52, 222-226.","DOI":"10.1002\/1097-0142(19830715)52:2<222::AID-CNCR2820520207>3.0.CO;2-K"},{"key":"key\n\t\t\t\t20171013103544_REF5","unstructured":"Grewal, J., Nestor, V., and Fink, K. (2005) Long term use of monthly temozolomide in patients with oligodendroglioma: Feasibility and tolerability of two years of therapy. Neurology64, A25 (abstract)."},{"key":"key\n\t\t\t\t20171013103544_REF6","doi-asserted-by":"crossref","unstructured":"Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A., and Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J. Clin. Oncol.17, 3835-3849.","DOI":"10.1200\/JCO.1999.17.12.3835"},{"key":"key\n\t\t\t\t20171013103544_REF7","doi-asserted-by":"crossref","unstructured":"Hoang-Xuan, K., Capelle, L., Kujas, M., Taillibert, S., Duffau, H., Lejeune, J., Polivka, M., Crinie\u0300re, E., Marie, Y., Mokhtari, K., Carpentier, A.F., Laigle, F., Simon, J.M., Cornu, P., Broe\u0308t, P., Sanson, M., and Delattre, J.Y. (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J. Clin. Oncol.22, 3133-3138.","DOI":"10.1200\/JCO.2004.10.169"},{"key":"key\n\t\t\t\t20171013103544_REF8","doi-asserted-by":"crossref","unstructured":"Pedersen-Bjergaard, J. (2005) Insights into leukemogenesis from therapy-related leukemia. N. Engl. J. Med.352, 1591-1594.","DOI":"10.1056\/NEJMe048336"},{"key":"key\n\t\t\t\t20171013103544_REF9","doi-asserted-by":"crossref","unstructured":"Pedersen-Bjergaard, J., Specht, L., Larsen, S.O., Ersboll, J., Struck, J., Hansen, M.M., Hansen, H.H., and Nissen, N.I. (1987) Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet2, 83-88.","DOI":"10.1016\/S0140-6736(87)92744-9"},{"key":"key\n\t\t\t\t20171013103544_REF10","doi-asserted-by":"crossref","unstructured":"Perry, J.R., Brown, M.T., and Gockerman, J.P. (1998) Acute leukemia following treatment of malignant glioma. J. Neurooncol.40, 39-46.","DOI":"10.1023\/A:1006175831785"},{"key":"key\n\t\t\t\t20171013103544_REF11","doi-asserted-by":"crossref","unstructured":"Rogers, L.R., Janakiraman, N., Kasten-Sportes, C., and Rosenblum, M.L. (2001) Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: Successful treatment with allogeneic bone marrow transplant. J. Neurooncol.53, 55-59.","DOI":"10.1023\/A:1011878214861"},{"key":"key\n\t\t\t\t20171013103544_REF12","doi-asserted-by":"crossref","unstructured":"Smith, S.M., Le Beau, M.M., Huo, D., Karrison, T., Sobecks, R.M., Anastasi, J., Vardiman, J.W., Rowley, J.D., and Larson, R.A. (2003) Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: The University of Chicago series. Blood102, 43-52.","DOI":"10.1182\/blood-2002-11-3343"},{"key":"key\n\t\t\t\t20171013103544_REF13","doi-asserted-by":"crossref","unstructured":"Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E., and Mirimanoff, R.O. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med.352, 987-996.","DOI":"10.1056\/NEJMoa043330"},{"key":"key\n\t\t\t\t20171013103544_REF14","doi-asserted-by":"crossref","unstructured":"Su, Y.W., Chang, M.C., Chiang, M.F., and Hsieh, R.K. (2005) Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma. J. Neurooncol.71, 315-318.","DOI":"10.1007\/s11060-004-2028-0"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/8\/3\/280\/13066132\/NO83_08_Noronha.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T10:36:06Z","timestamp":1507890966000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/8\/3\/280\/1039802\/Treatmentrelated-myelodysplasiaAML-in-a-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,1]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,7,1]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1215\/15228517-2006-003","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,7,1]]}}}